Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 321
Selected: 0
NCT IDTitle
NCT05603884VCA Regimen Followed by D-MAG Regimen on the Treatment of Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)
NCT05192681Tislelizumab as Cross-line Treatment for Advanced NSCLC
NCT05907447A Retrospective Study on Extranodal Lymphoma or Lymphoma of Rare Pathological Types
NCT01398449Is ENI Necessary For Patients With Thoracic Esophageal Cancer After Esophagectomy And With Pathological Stage Of T1-2,N+,M0
NCT05335460To Determine the Efficacy and Safety of Envafolimab Combined With XELOX for Locally Advanced Colon Cancer
NCT06995118The Application of "HUAXI Hole 1" in Reverse-sequence Endoscopic Nipple-sparing Mastectomy With Direct-to-implant Breast Reconstruction
NCT02026362Multiple Antigen Specific Cell Therapy (MASCT) for Hepatocellular Carcinoma(HCC) Patients After Radical Resection or Radio Frequency Ablation(RFA).
NCT07185308Postbiotics Ameliorate Cachexia in Patients With Non-small-cell Lung Cancer
NCT02113423Intensity Modulated Radiotherapy in Recurrent T1-2 Nasopharyngeal Carcinoma
NCT07303283Becotatug Vedotin as Adjuvant Therapy For High-risk Nasopharyngeal Carcinoma
NCT03258034A Feasibility Study for Convernsion Therapy Using S1/Paclitaxel Chemotherapy Plus Apatinib in ELM Gastric Cancer
NCT06126393MRI Radiomics Combined With Pathomics on the Prediction of Molecular Classification and Prognosis of Endometrial Cancer
NCT05938309A Cohort Study on the Safety of Laparoscopic Resection of 5cm or Larger Gastric Gastrointestinal Stromal Tumors
NCT07320963Chidamide in Combination With Toripalimab and Anlotinib in Recurrent/Metastatic Nasopharyngeal Carcinoma.
NCT07237828Drain Removal on Postoperative Safety and Patient Satisfaction in R-E-NSM With Prepectoral DIBR
NCT04555226The Efficacy of Lymph Node Dissection for Stage IIICr of Cervical Cancer(CQGOG0103)
NCT07541001PRL3-Zumab in Patients With Advanced Solid Tumors
NCT06220630The Characteristics, Treatment Patterns and Prognosis of Chinese Male Breast Cancer: A Real-world Study
NCT05648994TCR-T Cells for the Treatment NY-ESO-1-positive Advanced Solid Tumors
NCT05663177Almonertinib Plus Metronomic Oral Vinorelbine
NCT05687851Study Of Cadonilimab Combined With Radiotherapy In The Treatment of Locally Advanced Cervical Cancer
NCT01218594Curative Effect Study of Endostatin Combined With Chemoradiotherapy to Non-small-cell Lung Cancer
NCT05235932the Clinical Efficacy of Robotic and Laparoscopic Radical Total Gastrectomy in Locally Advanced Middle and Upper Gastric Cancer
NCT06814067Phase II Multi-centered Study of Perioperative Ivonescimab Versus Pembrolizumab Combined with Standard of Care (SOC) in Patients with Resectable, Locally Advanced Head and Neck Squamous Cell Carcinoma
NCT03872635Effects of Anesthesia on Tumor Immunity and Insulin Resistance During Perioperative Period
NCT05751265Tislelizumab Combined With Chemotherapy in the Cross-line Treatment of First-line Resistant Advanced Gastric Cancer
NCT04844645Using Mini Program for Self-management VS Conventional Pharmaceutical Care for Cancer Pain
NCT06692270Tislelizumab as Single-Agent Neoadjuvant Immunotherapy in Resectable Esophageal Squamous Cell Carcinoma
NCT04074538the National Colorectal Cancer Cohort (NCRCC) Study: National Colorectal Cancer Research Consortium
NCT05001360Study of FMT Combined With Nivolumab in Gastric Cancer
NCT04785768IV PCA With or Without Continuous Dose vs Oral Opioid to Maintain Analgesia for Severe Cancer Pain After Successful Titration
NCT04443478Laparoscopic Versus Open Lower Mediastinal Lymphadenectomy for Esophagogastric Junction Cancer
NCT03286920Effect of Postoperative Family Nutrition Mode on Weight/BMI of Patients With Esophageal Cancer
NCT05007145PD-1 Inhibitor Combined With Neoadjuvant Chemotherapy in Subjects With Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma
NCT06066216Cadonilimab (AK104) Plus Chemotherapy in Patients With Recurrent or Advanced Endometrial Cancer
NCT06577792Lobectomy-First vs. Lymphadenectomy-First for Operable NSCLC (LOFTY)
NCT03637634The Children and Adolescents Nasopharyngeal Carcinoma Survivor Study
NCT05019690Apatinib Combined with Albumin-Bound Paclitaxel for Treatment of Advanced Triple Negative Breast Cancer
NCT07402525Postoperative Radiotherapy for Early-stage Oral Tongue Squamous Cell Carcinoma Patients With Risk Factors: a Prospective, Multicenter, Randomized Controlled, Open-labelled Trial
NCT05897138A Study to Evaluate Lenvatinib Plus Tislelizumab for Locally Advanced Unresectable or Metastatic Hepatocellular Carcinoma With Hepatitis B Virus Infection and Biomarker Analyses
NCT04920214Application Value of CEUS Li-RADS in Hepatic Focal Lesions in Patients With Non-high Risk Factors for HCC
NCT06713421Effect of Premedication With Pronase on Mucosal Cleanliness During EGD
NCT05699655Tislelizumab Combined With Apatinib and Oxaliplatin Plus S1 Vs Oxaliplatin Plus S1 as Neoadjuvant Therapy for Borrmann IV、Large Borrmann III Type and Bulky N Positive Advanced Gastric Cancer
NCT05955391TGRX-326 Chinese Phase II for Advanced Non-small Cell Lung Cancer (NSCLC)
NCT06737913HAI or IV of Adebrelimab, Combined With Bevacizumab and HAI of FOLFOX for Advanced Unresectable Hepatocellular Carcinoma
NCT04421469Triprilimab(JS001) and Chemotherapy Combined With Local Treatment for Multiple Metastatic NPC
NCT06078670PARP Inhibitor CVL218 in Combination Therapy for Patients With Advanced Solid Tumors
NCT06149767Clinical Study of Adebrelimab Combined With Concurrent Chemoradiotherapy in Cervical Cancer
NCT06699459Irinotecan Liposomes +5-FU/LV Versus Capecitabine in Patients of Recurrence After Resection of Resectable BTC
NCT05223088Tislelizumab Combined With Apatinib and Oxaliplatin Plus S1 as Neoadjuvant Therapy for Borrmann IV、Large Borrmann III Type and Bulky N Positive Advanced Gastric Cancer